Author: Boundless Bio, Inc.

Posted Date:

March 17, 2026

Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026

Boundless Bio, Inc.

March 17, 2026
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Boundless Bio, Inc.

March 9, 2026
Boundless Bio to Participate in the Leerink Global Healthcare Conference

Boundless Bio, Inc.

March 4, 2026
Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Boundless Bio, Inc.

February 7, 2026